Yonghao Yang

523 total citations
39 papers, 292 citations indexed

About

Yonghao Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Yonghao Yang has authored 39 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Yonghao Yang's work include Cancer Immunotherapy and Biomarkers (16 papers), CAR-T cell therapy research (12 papers) and Sarcoma Diagnosis and Treatment (7 papers). Yonghao Yang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), CAR-T cell therapy research (12 papers) and Sarcoma Diagnosis and Treatment (7 papers). Yonghao Yang collaborates with scholars based in China, United States and United Kingdom. Yonghao Yang's co-authors include Lingdi Zhao, Quanli Gao, Tiepeng Li, Yiman Shang, Hongwei Lin, Zhichao Tian, Yong Zhang, Jiaqiang Wang, Zibing Wang and Jinpo Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yonghao Yang

35 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonghao Yang China 11 200 93 77 41 38 39 292
Helen Clare Dearden United Kingdom 5 316 1.6× 90 1.0× 82 1.1× 58 1.4× 22 0.6× 13 368
Kai Qing China 12 86 0.4× 174 1.9× 52 0.7× 70 1.7× 68 1.8× 35 351
George Mo United States 8 165 0.8× 52 0.6× 82 1.1× 89 2.2× 21 0.6× 19 345
Fred Hardwicke United States 9 222 1.1× 60 0.6× 45 0.6× 69 1.7× 39 1.0× 36 377
Wolfgang Moersig Germany 7 336 1.7× 87 0.9× 251 3.3× 60 1.5× 21 0.6× 12 432
Chenliang Zhou China 8 83 0.4× 67 0.7× 58 0.8× 182 4.4× 47 1.2× 20 318
Ephraim Tang Canada 9 226 1.1× 69 0.7× 115 1.5× 41 1.0× 89 2.3× 19 337

Countries citing papers authored by Yonghao Yang

Since Specialization
Citations

This map shows the geographic impact of Yonghao Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghao Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghao Yang more than expected).

Fields of papers citing papers by Yonghao Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghao Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghao Yang. The network helps show where Yonghao Yang may publish in the future.

Co-authorship network of co-authors of Yonghao Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghao Yang. A scholar is included among the top collaborators of Yonghao Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghao Yang. Yonghao Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yonghao, Hao Yu, Ye Chen, et al.. (2025). Tuning the charge trapping properties of organic field-effect transistor memories via a co-evaporated bulk heterojunction approach. Surfaces and Interfaces. 65. 106493–106493.
2.
Xu, Benling, Tingjie Wang, Peng Qin, et al.. (2025). The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis. Scientific Reports. 15(1). 17450–17450. 1 indexed citations
3.
Tian, Zhichao, Yang Yang, Yonghao Yang, et al.. (2024). Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives. Frontiers in Pharmacology. 15. 1335054–1335054. 2 indexed citations
4.
Mao, Xi, Yonghao Yang, Lisong Yang, et al.. (2024). Orthogonal printing of uniform nanocomposite monolayer and oriented organic semiconductor crystals for high-performance nano-crystal floating gate memory. Journal of Colloid and Interface Science. 668. 232–242. 2 indexed citations
5.
Wu, Jianxun, et al.. (2023). Stability Analysis Method for Initial Support Structure of Tunnel in Swelling Loess. Processes. 11(4). 1090–1090. 1 indexed citations
6.
7.
Yang, Yonghao, et al.. (2023). Indole-3-carboxaldehyde ameliorates ionizing radiation-induced hematopoietic injury by enhancing hematopoietic stem and progenitor cell quiescence. Molecular and Cellular Biochemistry. 479(2). 313–323. 7 indexed citations
8.
9.
Peng, Ling, Bicheng Zhang, Brian G. Till, et al.. (2022). Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies. Frontiers in Immunology. 13. 882172–882172. 4 indexed citations
10.
Tian, Zhichao, Shuping Dong, Po Li, et al.. (2022). Efficacy and safety of sintilimab plus doxorubicin in advanced soft tissue sarcoma: A single-arm, phase II trial. Frontiers in Pharmacology. 13. 987569–987569. 7 indexed citations
11.
Shang, Yiman, Yong Zhang, Xiaomin Fu, et al.. (2022). Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer. Frontiers in Oncology. 12. 852885–852885. 5 indexed citations
12.
Yang, Yonghao, et al.. (2021). Axitinib Reverses Resistance to Anti-Programmed Cell Death-1 Therapy in a Patient With Renal Cell Carcinoma. Frontiers in Immunology. 12. 728750–728750. 4 indexed citations
13.
Yang, Yonghao, Jun Li, Brian G. Till, et al.. (2021). Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma. Frontiers in Oncology. 11. 728253–728253. 2 indexed citations
14.
Zhao, Lingdi, et al.. (2020). Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell Cancer. Frontiers in Oncology. 10. 507–507. 3 indexed citations
15.
Tian, Zhichao, Yang Yang, Yonghao Yang, et al.. (2020). High cumulative doxorubicin dose for advanced soft tissue sarcoma. BMC Cancer. 20(1). 1139–1139. 27 indexed citations
16.
Wei, Zuoan, Yulong Chen, Guangzhi Yin, Yonghao Yang, & W. M. Shu. (2019). An alternative upstream method for the Zhelamuqing tailings impoundment construction of a Copper Mine in China. Geomechanics and Engineering. 19(5). 383–392. 5 indexed citations
17.
Fu, Xiaomin, Yong Zhang, Jing Yang, et al.. (2018). Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer. OncoTargets and Therapy. Volume 11. 6091–6100. 13 indexed citations
18.
Zhang, Yong, et al.. (2018). Platelet-to-lymphocyte ratio in peripheral blood: A novel independent prognostic factor in patients with melanoma. International Immunopharmacology. 56. 143–147. 17 indexed citations
19.
20.
Wang, Zibing, Yuqing Liu, Yiman Shang, et al.. (2016). Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer. Journal of Hematology & Oncology. 9(1). 6–6. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Clare Dearden Breakdown of academic impact, for papers by Kai Qing Breakdown of academic impact, for papers by George Mo Breakdown of academic impact, for papers by Fred Hardwicke Breakdown of academic impact, for papers by Wolfgang Moersig Breakdown of academic impact, for papers by Chenliang Zhou Breakdown of academic impact, for papers by Ephraim Tang
Rankless by CCL
2026